In a recent study, the use of vitamin D binding proteins (DBPs), which have been shown to suppress amyloid-related pathology in the brain, has been proposed to slow down the progression of cognitive decline in AD [18-19]. The gene discussed is GC; the disease is Alzheimer disease.